
FAAH
Fatty Acid Amide Hydrolase (FAAH) is an enzyme that breaks down fatty acid amides, including endocannabinoids like anandamide. These compounds are involved in the regulation of pain, mood, appetite, and memory. Inhibition of FAAH can increase the levels of these signaling molecules, offering potential therapeutic benefits for pain, anxiety, and neurodegenerative diseases. At CymitQuimica, we offer a selection of FAAH inhibitors to support your research in neuroscience, pain management, and endocannabinoid signaling.
Products of "FAAH"
Sort by
MM-433593
CAS:MM-433593 is a selective fatty acid amide hydrolase (FAAH-1) inhibitor for the treatment of pain, inflammation, and other disorders.Formula:C25H22ClN3O3Purity:100%Color and Shape:SolidMolecular weight:447.91Dual FAAH/sEH-IN-1
CAS:Dual FAAH/sEH-IN-1 inhibits both sEH (IC50: 9.6 nM) and FAAH (IC50: 7 nM), offering potent anti-inflammatory effects.Formula:C25H22ClN3O3S2Purity:99.89%Color and Shape:SolidMolecular weight:512.04Ref: TM-T63536
1mg140.00€5mg331.00€10mg439.00€25mg667.00€50mg894.00€100mg1,198.00€200mg1,596.00€1mL*10mM (DMSO)406.00€2-Chlorophenylboronic acid
CAS:2-Chlorophenylboronic acid: A monohalogenated phenylboronic acid used in drug synthesis and as a fatty acid amidase inhibitor.Formula:C6H6BClO2Purity:99.42%Color and Shape:SolidMolecular weight:156.37